National Health Investors Inc.

05/07/2025 | Press release | Distributed by Public on 05/07/2025 14:07

Statement of Changes in Beneficial Ownership (Form 4)

FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Mendelsohn D. Eric
2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [NHI] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
CEO and President
(Last) (First) (Middle)
222 ROBERT ROSE DRIVE 		3. Date of Earliest Transaction (Month/Day/Year)
05/05/2025
(Street)
MURFREESBORO, TN 37129 		4. If Amendment, Date Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) 		7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 05/05/2025 F 394 D $76.04 96,133(1) D
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5) 		6. Date Exercisable and Expiration Date
(Month/Day/Year) 		7. Title and Amount of Underlying Securities
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4) 		10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4) 		11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) 2-25-2021 $69.2 02/25/2021 02/25/2026 Common Stock 41,666 41,666 D
Stock Options (Right to Buy) 2-25-2021 $69.2 02/25/2022 02/25/2026 Common Stock 41,666 41,666 D
Stock Options (Right to Buy) 2-25-2021 $69.2 02/25/2023 02/25/2026 Common Stock 41,668 41,668 D
Stock Option (Right to Buy) 2023 $54.73 02/24/2025 02/24/2028 Common Stock 13,334 13,334 D
Stock Option (Right to Buy) 2024 $57.76 02/23/2025 02/23/2029 Common Stock 13,333 13,333 D
Stock Option (Right to Buy) 2024 $57.76 02/23/2026 02/23/2029 Common Stock 13,334 13,334 D
Stock Option (Right to Buy) 2025 $73.34 03/03/2025 03/03/2030 Common Stock 25,000 25,000 D
Stock Option (Right to Buy) 2025 $73.34 03/03/2026 03/03/2030 Common Stock 25,000 25,000 D
Stock Option (Right to Buy) 2025 $73.34 03/03/2027 03/03/2030 Common Stock 25,000 25,000 D

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Mendelsohn D. Eric
222 ROBERT ROSE DRIVE
MURFREESBORO, TN 37129 		X CEO and President

Signatures

/s/Kimberly V. Ouimet, by limited power of attorney 05/07/2025
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Reflects the disposition of 394 restricted shares upon vesting on May 5, 2025 for the settlement of taxes.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
National Health Investors Inc. published this content on May 07, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on May 07, 2025 at 20:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io